v3.25.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   96,787,000      
Beginning balance at Dec. 31, 2023 $ 88,667 $ 9 $ 1,070,558 $ 4 $ (981,904)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares of common stock net of discount and issuance costs of $10,820 (in shares)   18,158,000      
Issuance of shares of common stock net of discount and issuance costs of $10,820 161,682 $ 3 161,679    
Issuance of common stock upon the exercise of stock options (in shares)   22,000      
Issuance of common stock upon the exercise of stock options 82   82    
Issuance of common stock upon the vesting of restricted stock units (in shares)   538,000      
Stock-based compensation expense 10,030   10,030    
Unrealized loss on marketable securities (116)     (116)  
Foreign currency translation adjustment (21)     (21)  
Net loss (35,382)       (35,382)
Ending balance (in shares) at Mar. 31, 2024   115,505,000      
Ending Balance at Mar. 31, 2024 224,942 $ 12 1,242,349 (133) (1,017,286)
Beginning balance (in shares) at Dec. 31, 2023   96,787,000      
Beginning balance at Dec. 31, 2023 88,667 $ 9 1,070,558 4 (981,904)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized loss on marketable securities (243)        
Foreign currency translation adjustment (55)        
Net loss (87,714)        
Ending balance (in shares) at Jun. 30, 2024   116,479,000      
Ending Balance at Jun. 30, 2024 186,427 $ 12 1,256,327 (294) (1,069,618)
Beginning balance (in shares) at Mar. 31, 2024   115,505,000      
Beginning balance at Mar. 31, 2024 224,942 $ 12 1,242,349 (133) (1,017,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   147,000      
Issuance of common stock upon the exercise of stock options 806   806    
Issuance of common stock upon the vesting of restricted stock units (in shares)   443,000      
Shares issued pursuant to the employee stock purchase plan (in shares)   384,000      
Shares issued pursuant to the employee stock purchase plan 649   649    
Stock-based compensation expense 12,523   12,523    
Unrealized loss on marketable securities (127)     (127)  
Foreign currency translation adjustment (34)     (34)  
Net loss (52,332)       (52,332)
Ending balance (in shares) at Jun. 30, 2024   116,479,000      
Ending Balance at Jun. 30, 2024 186,427 $ 12 1,256,327 (294) (1,069,618)
Beginning balance (in shares) at Dec. 31, 2024   117,848,000      
Beginning balance at Dec. 31, 2024 157,541 $ 12 1,279,479 (7) (1,121,943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   110,000      
Issuance of common stock upon the exercise of stock options 395   395    
Issuance of common stock upon the vesting of restricted stock units (in shares)   1,180,000      
Stock-based compensation expense 9,915   9,915    
Unrealized loss on marketable securities (137)     (137)  
Foreign currency translation adjustment 4     4  
Net loss (25,060)       (25,060)
Ending balance (in shares) at Mar. 31, 2025   119,138,000      
Ending Balance at Mar. 31, 2025 142,658 $ 12 1,289,789 (140) (1,147,003)
Beginning balance (in shares) at Dec. 31, 2024   117,848,000      
Beginning balance at Dec. 31, 2024 $ 157,541 $ 12 1,279,479 (7) (1,121,943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares) 129,217        
Unrealized loss on marketable securities $ (232)        
Foreign currency translation adjustment 204        
Net loss (40,946)        
Ending balance (in shares) at Jun. 30, 2025   119,798,000      
Ending Balance at Jun. 30, 2025 138,974 $ 12 1,301,886 (35) (1,162,889)
Beginning balance (in shares) at Mar. 31, 2025   119,138,000      
Beginning balance at Mar. 31, 2025 142,658 $ 12 1,289,789 (140) (1,147,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   19,000      
Issuance of common stock upon the exercise of stock options 61   61    
Issuance of common stock upon the vesting of restricted stock units (in shares)   522,000      
Shares issued pursuant to the employee stock purchase plan (in shares)   119,000      
Shares issued pursuant to the employee stock purchase plan 1,319   1,319    
Stock-based compensation expense 10,717   10,717    
Unrealized loss on marketable securities (95)     (95)  
Foreign currency translation adjustment 200     200  
Net loss (15,886)       (15,886)
Ending balance (in shares) at Jun. 30, 2025   119,798,000      
Ending Balance at Jun. 30, 2025 $ 138,974 $ 12 $ 1,301,886 $ (35) $ (1,162,889)